The companies within AddLife continue to develop in line with our priorities. Margins are strengthening in both business areas thanks to continuous development of product portfolios and good cost control. Growth was strong in Labtech, and in Medtech, demand was steadily increasing, but was held back somewhat, mainly due to the timing of capital investments in certain countries. Our acquired companies are contributing further to the positive development of margins and growth. Profit for the period improved by 39 percent in the quarter.
A European partner in Life Science
Our vision is to improve people's lives by being a leading, value-adding partner in Life Science
Interim Report Q2 2025
Share price
Press Releases
Report
Calendar
-
![Fredrik Dalborg Addlife Q2 2025 2]()
-
AddLife acquires Edge Medical Ltd
To Edge MedicalEdge Medical Ltd is a leading distributor of specialty products in the field of orthopedic surgery in the UK and Irish markets. The company’s offering includes products for orthopedic surgery including, spine, biologics, pain management as well as products supporting the rising demand for minimally invasive procedures. The company has sales of approximately GBP 8 million and 23 employees and will be included in AddLife’s business area Medtech.
![Orthopaedic Surgery Image]()
Our business areas
MEDTECH
In the Medtech business area, the subsidiaries offer products and services in medical technology, as well as assistive equipment and digital solutions for use in home care. Medtech has two business units - Hospital and Homecare. The Medtech offering mainly focuses on publicly funded healthcare, home care and social care in Europe.
Read more
LABTECH
The Labtech business area provides products, solutions and services in fields such as diagnostics, biomedical research and laboratory analysis. The business area consists of two business units: Biomedical and Research and Diagnostics. The most important customer groups are hospital laboratories, academic research and pharmaceutical companies in Europe.
Read moreJoin the AddLife group
Do you have a Life Science company with opportunities to grow? We offer an attractive option with a decentralized business model where we combine the strength of a large enterprise with the dedication and business skills of an entrepreneur. As an AddLife subsidiary, you are responsible for your business activities within the AddLife requirements for growth, profitability and sustainable development.
News from our subsidiaries
10 July 2025
Midsummer celebration at MBA
Like our colleagues in Sweden, last June we joined their traditional summer welcome celebration with our very own MBA Midsommar.
MBA
19 June 2025 | HC21
Healthcare21Group launching the PROCEPT BioRobotics in Dublin
The significant technological advancements in Robotics will help us to drive growth and future proof our businesses to the evolving needs of their customers to help improve lives in the most efficient way possible.
15 May 2025 | Hepro
Hepro strengthens its position in the Nordics with a record welfare technology contract in Sweden
Increased safety for people living at home in 48 municipalities
26 March 2025 | AddLife
Supporting active Ukrainian military medics
Yesterday, AddLife took part in a significant initiative alongside Repower, Region Uppsala, and Akademiska sjukhuset in Uppsala. The project aimed to support active Ukrainian military medics by helping them prevent complex psychological disorders, regain strength, and restore motivation for continued service.
Sustainability for AddLife
Sustainability is a central part of AddLife's vision to improve people's life by being a leading, value adding provider in Life Science. AddLife´s approach to sustainability is identified through three impact areas where we can have the greatest contribution to a long-term lasting business and society.
